NATIONAL INSTITUTES OF HEALTH ISSUES NOTICE: GOVERNMENT OWNED INVENTION AVAILABLE FOR LICENSE: SELECTIVE EXPANSION OF ENGINEERED TCR-T CELLS FOR USE IN ADOPTIVE CELL IMMUNOTHERAPY

WASHINGTON, July 16 -- National Institutes of Health has issued a notice called: Government Owned Invention Available for License: Selective Expansion of Engineered TCR-T Cells for Use in Adoptive Cell Immunotherapy.

The notice was published in the Federal Register on July 16 by Richard U. Rodriguez, Associate Director, Technology Transfer Center, National Cancer Institute.

Summary: The National Cancer Institute (NCI) seeks capable licensees interested in commercializing T cell receptor (TCR)-engineered T cells expressing murine/human hybrid receptors.

For more information, contact Inquiries related to this license opportunity should be directed to: Andrew Burke, Ph.D. at Email: [e-mail] Phone: [phone].

The full text ...